BioCentury
ARTICLE | Financial News

CAMP4 Therapeutics launches with $30M series A

May 31, 2018 12:31 PM UTC

CAMP4 Therapeutics Corp. (Cambridge, Mass.) launched with an untranched $30 million series A round led by new investor Andreessen Horowitz. Existing investors The Kraft Group and Polaris Partners also participated.

A CAMP4 spokesperson told BioCentury that the round will provide 12-18 months of cash...